 API |
| INTERMEDIATE |
|
 |
|
| |
 |
|
 |
|
 |
 General Information
Shanghai Henghe Pharmaceutical Technology Co., Ltd is a leading process R&D, Intermediates and API manufacturing service provider to the global pharmaceutical industry.
With GMP-Compliance production facilities and Knowledge-based R&D activity, Henghe offers a wide portfolio of high value API and Intermediates to brand companies for the generic Pharmaceutical industry.
Combining cost-effective resources and productivity of China along with unmatched network of high class professionals, Henghe is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
Please visit our subordinate facility website: www.biotaxu.com
Henghe Advantage
In order to guarantee the high quality of product, we have established GMP standard production base and laboratory which are major in the extraction, separation, purification and synthesis of oncology APIs and their intermediates. Currently we own two patents for Paclitaxel intermediate 10-DAB III . Also our sub-factory has been approved by ISO 9001.
Our commitment to excellence in quality, environmental protection, safety and production will be pursued in a highly professional manner and with a sense of urgency while upholding the highest business ethics. We emphasize extremely responsive customer service by using a dedicated team assigned specifically to the project under the direction of a R&D project manager.
Looking through our growth, we attribute our success to our Professionalism, Flexibility and In-Depth Knowledge. .[More] |
|
|
We will participate at the following exhibitions in 2008
-CPHI India,
Nov. 28 - Nov. 30: Stand N0. CP02 (Hall 6)
-CPHI Worldwide,
Sept. 30-Oct. 02 2008: Stand No. CP51083
-CPHI South
America, Aug. 19-21 2008: Stand no. C36
-CPHI Shanghai,
24-26 June. 2008: Stand no. 4F32 |
|
